. These 1gM polymers also consisted of mixtures of hexamers and pentamers. Davis et al. (3) demonstrated that the hexameric form of the IgM molecule was functional. They found that hexameric IgM activated the complement cascade in hemolytic assays up to 20-fold more efficiently than pentameric IgM, an observation confirmed and extended in our own studies (9). We found that inducible B-cell lines could secrete IgM hexamers, but the relative levels of hexameric to pentameric IgM varied depending on the cell line, thus leading to differences in the activity of the secreted IgM. Taken together, these studies show that J chain is not required for either assembly or secretion of IgM. It is unclear, however, if the production of hexamers is an intrinsic property of particular cell lines, such that they cannot polymerize IgM "correctly," or if the ratio of IgM hexamers and pentamers reflects a limited abundance or inaccessibility of J chain to the polymerizing IgM. When J chain is absent or in limited supply, a sixth IgM monomer might be inserted into the assembling polymer in place of J chain.
mixtures of IgM hexamers and pentamers, resulting in antibody with high complement-fiting activity. In contrast, interleukin-5-stimulated CH12 cells secreted predominately pentameric IgM, with a correspondingly lower lytic activity. Differences in lytic activity were due only to the amount of hexameric IgM in the secreted antibody. Interleukin 5 stimulated higher production of J chain RNA and protein than LPS, while LPS induced the highest levels of the secretory form of IA protein. The amount of hexameric 1gM secreted was therefore inversely proportional to the level of intracellular J chain protein in the responding B cells. We conclude that the biologic function of igM produced by B cells differs depending on how they are stimulated and that this difference may be regulated by the relative availabilities ofJ chain and secretory is proteins during IgM polymerization.
Classically, the IgM polymer is visualized as a pentamer of five H2L2 (H, heavy chain; L, light chain) monomeric suibunits covalently associated by disulfide bonds and containing a single J or joining chain (1) . J chain is a 15-kDa protein that is disulfide bonded to at least two ofthe , H chains in the final polymer via the terminal cysteine, Cys-575, and/or Cys-414 (2-4). J chain does not contribute to the antigen specificity of the molecule, but it was originally hypothesized to be required for the polymerization and secretion of pentameric IgM (5-7). However, not all secreted IgM contains J chain or is pentameric. A hexameric form of IgM was identified in some of the earlier electron microscopic studies of polymeric IgM secreted by the plasmacytoma MOPC 104E, but the significance and function of this molecule was not investigated (8) . Recently, we and others have shown that this hexameric form of IgM can account for a significant fraction of the secreted IgM from some B-cell lines and, like the pentamer, constitutes a functional molecule (3, 9) . Unlike the pentamer, the hexamer is never observed with J chain. However, even pentamer assembly and secretion does not require J chain. A glioma cell line expressing transfected A and K molecules in the absence of J chain secreted IgM that consisted of both hexamers and pentamers (10) . Further (3, 4) . These 1gM polymers also consisted of mixtures of hexamers and pentamers. Davis et al. (3) demonstrated that the hexameric form of the IgM molecule was functional. They found that hexameric IgM activated the complement cascade in hemolytic assays up to 20-fold more efficiently than pentameric IgM, an observation confirmed and extended in our own studies (9) . We found that inducible B-cell lines could secrete IgM hexamers, but the relative levels of hexameric to pentameric IgM varied depending on the cell line, thus leading to differences in the activity of the secreted IgM. Taken together, these studies show that J chain is not required for either assembly or secretion of IgM. It is unclear, however, if the production of hexamers is an intrinsic property of particular cell lines, such that they cannot polymerize IgM "correctly," or if the ratio of IgM hexamers and pentamers reflects a limited abundance or inaccessibility of J chain to the polymerizing IgM. When J chain is absent or in limited supply, a sixth IgM monomer might be inserted into the assembling polymer in place of J chain.
In the current study, we have tested this hypothesis. From earlier work using the inducible B-cell lymphoma CH12, we had found that synthesis of J chain RNA could be stimulated to a greater extent by lymphokine-containing supernatants than by lipopolysaccharide (LPS) (11) . Here we demonstrate that while both LPS and interleukin (IL)-5 stimulate the differentiation of CH12 cells, IL-5 stimulates the production ofJ chain protein to a higher level than LPS. This differential stimulation correlates with the production of fewer IgM hexamers in the IL-5-stimulated population, thus lowering the biological activity of the secreted IgM, as measured by activation of the complement cascade. The functional significance of this result for our understanding of the regulation of the primary immune response is discussed.
MATERIALS AND METHODS
Cell Culture and Plaque-Forming Cell (pfc) Assays. The B-cell lymphoma CH12 was passaged in vivo as ascites cells and cultured as described (12) . All ELISA and Hemolysis Assays. Quantitative ELISA for determining IgM concentrations and quantitative hemolysis assays for determining hemolysis of BrSRBC were performed exactly as described (14) .
Northern Blotting. Total cellular RNA was isolated and analyzed by Northern blotting as previously described (11, 12) . Probes were isolated as inserts from cDNA clones and labeled by "random priming" according to the supplier's specifications (Pharmacia) as described by Feinberg and Vogelstein (15) . Clones used were pu107 for u chain, pAJ5 for J chain, and pHF-1 for actin, which have been described (11) . The clone pSC33, containing a 500-base-pair (bp) 3' portion of the K constant region, was used as a K probe (16) .
RESULTS
Immunoglobulin and J Chain Gene Expression in LPS-and Lymphokine-Stimulated CH12 Cells. Since IL-2 and IL-5 have been shown to stimulate J chain production in BCL1 cells (17, 18) , we stimulated CH12 cells with various combinations of IL-2 and IL-5 and compared immunoglobulin and J chain transcript levels with those from CH12 cells stimulated with LPS ( Fig. 1) . RNA from unstimulated CH12 cells exhibited two ,u transcripts, with the a.m transcripts equal or greater in abundance than ,.s transcripts, consistent with a replicating B-cell phenotype (12) . As expected, LPS stimulation leads to significant increases in As, K, and J chain transcripts. IL-5 also stimulated production of these transcripts in CH12 cells and, interestingly, while increases in ,u and K were slightly less than those stimulated by LPS, J chain transcript levels were clearly higher. IL-2 appeared to have little effect on RNA levels in CH12 cells, either alone or in combination with IL-5. Addition of anti-,u to lymphokinecontaining cultures had no additional effect on mRNA levels (not shown) or on secretory rates (see Table 1 ).
We next examined ,u and J chain protein levels in extracts of stimulated CH12 cells by Western blotting. As shown in Fig. 2 , the expression of u was most significantly increased by LPS stimulation and the increase was confined to the secretory form of , protein. Although IL-5 stimulation also increased pu protein, these increases were not as great as with LPS. Furthermore, the increases in , were not equally reflected in the levels of J chain. While LPS did stimulate increases in J chain protein compared with unstimulated cells, the levels of J chain protein were Fig. 2. CH12 cells responded to IL-5 in a dose-dependent manner (Fig. 4) . The secretory rates were increased above background at concentrations of IL-5 as low as 5 units/ml and leveled off at concentrations of IL-5 between 60 and 250 units/ml. At these concentrations, the secretory rates were only slightly lower than those of LPS-stimulated cells.
Fig . 5 shows the polymeric IgM content of supernatants from CH12 cells stimulated as indicated in Fig. 4 more efficient at activating complement than are IgM pentamers in hemolysis assays (3, 9) . Thus, secreted IgM from CH12 cells stimulated with LPS should be more efficient in its hemolytic activity than IgM secreted by IL-5-stimulated CH12 cells. Consistent with this, we observed that hemolytic plaques from LPS-stimulated CH12 cells were significantly larger than plaques produced by the same cells stimulated with IL-5 (data not shown). To eliminate the possibility that differences in plaque size were due to different secretory rates, we measured the secretory rate of cells from LPS-stimulated cultures and compared these with the secretory rates of cells stimulated with IL-5 at 25 units/ml (Table 1) . Although the overall secretory rate was highest in cells from the LPSstimulated cultures, more cells responded to LPS by differentiating into pfc. When secretory rates were expressed relative to the numbers of pfc in the cultures, no difference between the rates of cells stimulated by LPS or IL-5 was found. These rates were calculated to be in the range of 3000-4000 molecules per cell per sec and are in the same range as those reported for myeloma and hybridoma cells (19) . It is interesting to note that the rates of secretion in all cultures were similar in magnitude, when calculated relative to the fraction ofpfc in the population. This was true even in cultures in which cells were not stimulated, such as those that were incubated with anti-p or IL-2 (see Table 1 and Fig. 6B ). This suggests that individual cells differentiate in an "all-or-none" manner, irrespective of which stimulus causes differentiation.
As a direct demonstration of changes in hemolytic activity, we compared the hemolytic efficiency of the secreted IgM from different cultures. The quantity of IgM in the supernatants was determined by ELISA, and the ability of the IgM to lyse BrSRBC was determined by quantitative hemolysis (20, 21) . Both of these properties depend on the ability of IgM to polymerize prior to secretion. Thus, the processes that control the polymerization of IgM play a critical role in the immune functions of the B cell. The IgM polymer is usually depicted as a pentamer of H2L2 subunits with one J chain subunit per pentamer (1) . This historic view of IgM structure has been challenged by recent data showing that the incorporation of J chain into polymerizing IgM is not essential for IgM polymer secretion (3, 9, 10) , and that hexameric IgM lacking in J chain possesses at least one of the (22) . Hexameric IgM has also been isolated from a patient with Waldenstrom macroglobulinemia (23), indicating that this form of IgM polymer can be found in the circulation. In our own studies, despite the inability to completely resolve hexamers and pentamers from normal mouse serum, we have observed mixtures of IgM hexamers and pentamers produced by B cells from mice expressing immunoglobulin g and K transgenes (unpublished).
What controls the final mix of IgM polymers secreted by B cells? CH12 cells respond to IL-S by increasing J chain levels well above those seen in LPS-stimulated cells (Fig. 2) . Furthermore, these cells secrete almost exclusively pentameric IgM (Fig. 3) . In recent experiments, we have found that IL-6 also induces high levels of J chain and the predominant secretion of IgM pentamers (unpublished data). Since the secretory rates of LPS-and IL-5-stimulated cells are very similar, it is unlikely that the production of hexamers is simply a phenomenon of a high secretory rate "overloading" the secretory pathway. However, our data showing that high levels of J chain correlate with IgM pentamer formation suggest that J chain may influence the type of polymers that are formed. In vitro data on IgM assembly support this conclusion. Kownatski (24) found that purified IgM monomers could reassemble in the absence of J chain but consisted of large amounts of hexameric as well as pentameric IgM. The addition of purified J chain during reassembly led to the formation of essentially pure pentameric IgM, suggesting that the formation of pentamers containing J chain is preferred. We suggest a model in which the assembly of IgM monomers into an open pentameric IgM is a rapid process (Fig. 7) . According to the data of Sitia et al. (25) , this molecule would not be secreted, since the free cysteine residues would cause it to be retained. To be secreted, the free terminal cysteines in the IgM molecule must be used by the covalent association with J chain or with other ,u chains. It is also likely that other factors, such as the abundance of disulfide isomerases (26, 27) or other proteins involved in the polymerization process, may influence the ratio of these two polymeric forms.
Why should the immune system have J chain at all, when it is not needed for the assembly or secretion of IgM, and IgM pentamers with J chain are less potent at complement activation than hexameric IgM without J chain? There must be properties intrinsic to immunoglobulin polymers containing J chain (both IgM and IgA) that are absent from polymers that lack J chain. Eskeland, Brandtzaeg, and co-workers (23, 28, 29) have hypothesized that J chain mediates the interaction of polymeric IgA and IgM with the poly immunoglobulin receptor, thus allowing the transcytosis of these polymers across epithelial cells into secretory compartments (21, 30) . In the case of IgM, the large benefit gained from the resulting secretory immunity may far outweigh the benefits of having increased lytic activity in the serum. It is also possible that IgM hexamers may be detrimental to the immune system under certain conditions. For example, if low-affinity "natural antibodies" become highly lytic, unwanted damage may occur. Finally, the synthesis of J chain by plasma cells not secreting polymeric immunoglobulin (13, 31) might suggest an as yet undiscovered role for J chain.
The ability to regulate J chain synthesis, and thus alter polymer production, may reflect an adaptive function of the immune system, which fine-tunes the relative abundance of the different polymeric forms of IgM to the type of pathogen involved in stimulation. In bacterial infections, the most effective response is clearance through complement activation, either by direct lysis or by opsonization. The increased production of IgM hexamers in immune responses to bacteria could therefore bestow a protective advantage. Interestingly, immune responses to many bacterial surface polysaccharides tend to be T-cell-independent and, like the response stimulated by LPS alone, might be expected to result in the increased production of hexameric IgM. On the other hand, the elimination of pathogens such as viruses do not normally require complement activation, since the binding of antibody alone usually leads to viral neutralization. As a result, production of hexamers would not necessarily be advantageous. Viral immune responses are usually helper T-celldependent, which should therefore promote increased J chain synthesis through the action of T-cell-derived lymphokines.
From these considerations, we suggest that there are three mechanisms whereby B cells can modify the biologic activity of their secreted antibody. The first two, isotype switching and somatic hypermutation, are predominately mechanisms that affect T-cell-dependent immune responses and are most evident in secondary B-cell responses (32) (33) (34) . The third, which we propose here, is the alteration of IgM hexamer and IgM pentamer production, which may have evolved to influence the biologic activity of primary antibody responses, and may distinguish the activity of antibodies secreted in T-celldependent and -independent immune responses. In vivo analysis will be necessary to directly test the validity of this hypothesis.
